Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Axtell

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2013
Th17 cells induce Th1-polarizing monocyte-derived dendritic cellsMatthew G Davidson, Michael N Alonso, Robert Yuan, et al.
Journal of the American Chemical Society|July 8, 2016
B-N, B-O, and B-CN Bond Formation via Palladium-Catalyzed Cross-Coupling of B-Bromo-CarboranesRafal M Dziedzic, Liban M A Saleh, Jonathan C Axtell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2015
IFN-β treatment requires B cells for efficacy in neuroautoimmunityRyan D Schubert, Yang Hu, Gaurav Kumar, et al.
Journal of the American Chemical Society|December 10, 2016
Blue Phosphorescent Zwitterionic Iridium(III) Complexes Featuring Weakly Coordinating nido-Carborane-Based LigandsJonathan C Axtell, Kent O Kirlikovali, Peter I Djurovich, et al.
Theranostics|January 3, 2022
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survivalKaili Liu, Ashley R Hoover, Jason R Krawic, et al.
The Journal of Biological Chemistry|February 7, 2012
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteinsJonathan B Rothbard, Michael P Kurnellas, Sara Brownell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brainXiaoying Zhuang, Xiaoyu Xiang, William Grizzle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2013
The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitisRodrigo Naves, Simer P Singh, Kevin S Cashman, et al.
Journal of Autoimmunity|September 14, 2019
Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine modelNeelakshi R Jog, Micah T McClain, Latisha D Heinlen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2025
Interferon-β treatment reverses the detrimental effect of B-cell depletion therapy on respiratory virus infectionBujana Allushi, Magdalena Chlebicz, Gaurav Kumar, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2013
Th17 cells induce Th1-polarizing monocyte-derived dendritic cellsMatthew G Davidson, Michael N Alonso, Robert Yuan, et al.
Journal of the American Chemical Society|July 8, 2016
B-N, B-O, and B-CN Bond Formation via Palladium-Catalyzed Cross-Coupling of B-Bromo-CarboranesRafal M Dziedzic, Liban M A Saleh, Jonathan C Axtell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2015
IFN-β treatment requires B cells for efficacy in neuroautoimmunityRyan D Schubert, Yang Hu, Gaurav Kumar, et al.
Journal of the American Chemical Society|December 10, 2016
Blue Phosphorescent Zwitterionic Iridium(III) Complexes Featuring Weakly Coordinating nido-Carborane-Based LigandsJonathan C Axtell, Kent O Kirlikovali, Peter I Djurovich, et al.
Theranostics|January 3, 2022
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survivalKaili Liu, Ashley R Hoover, Jason R Krawic, et al.
The Journal of Biological Chemistry|February 7, 2012
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteinsJonathan B Rothbard, Michael P Kurnellas, Sara Brownell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brainXiaoying Zhuang, Xiaoyu Xiang, William Grizzle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2013
The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitisRodrigo Naves, Simer P Singh, Kevin S Cashman, et al.
Journal of Autoimmunity|September 14, 2019
Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine modelNeelakshi R Jog, Micah T McClain, Latisha D Heinlen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2025
Interferon-β treatment reverses the detrimental effect of B-cell depletion therapy on respiratory virus infectionBujana Allushi, Magdalena Chlebicz, Gaurav Kumar, et al.
Pageof 16